Triple Helix Discovery Engine
"Triple Helix" Innovation Model
1. Triple Helix _ Sectors
4. Intermediaries ... Investors, Lenders, NonProfits, Specialists (Legal, IP, Marketing, Consultants, SMEs, Etc.)
5. Intermediary (Investors, Funders, Regulator) Rankings, Ratings & Reviews
Intermediaries: Geographic Info
*Bioscience Regional Clusters & HotSpots
*Industry: Massachusetts
OpenEvidence

Organization & Developments: OpenEvidence

Parents

* Verified medical professionals can access OpenEvidence’s tool, which is supported by advertising, for free.
*AI-powered information platform that organizes medical knowledge and makes it more useful, open, accessible, and understandable.
*OpenEvidence announced that The New England Journal of Medicine has become a content partner, meaning clinicians using OpenEvidence can benefit from content sourced from NEJM Group journals.
*Platform uses artificial intelligence to aggregate, synthesize, and visualize clinically relevant evidence in understandable, accessible formats
*Trained on medical journals like JAMA and the New England Journal of Medicine, the OpenEvidence platform helps users quickly get answers to existing medical knowledge to help treat patients.
2023: OpenEvidence AI becomes the first AI in history to score above 90% on the United States Medical Licensing Examination (USMLE)
2025: AI-powered platform designed to help healthcare professionals find and understand the latest medical evidence, acting as a tool to organize and synthesize information from peer-reviewed literature and other trusted sources
2025: OpenEvidence AI, the large language model-based artificial intelligence powering the automatic ingestion, analysis, synthesis, and research on openevidence.com
2025: OpenEvidence is now fully HIPAA compliant
2025: Partnering with OpenEvidence: A Life-Saving Healthcare Revolution
2026: OpenEvidence scores $250M, doubles valuation to $12B